Loading...

Ogechi Ikediobi

Title(s)Resident Physician, Dermatology
SchoolHealth Sciences
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Röhrich CR, Drögemöller BI, Ikediobi O, van der Merwe L, Grobbelaar N, Wright GE, McGregor N, Warnich L. CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women. AIDS Res Hum Retroviruses. 2016 06; 32(6):529-38. PMID: 26655325.
      View in: PubMed
    2. Ikediobi O, Chen YC, Shinkai K. Familial secondary hyperhidrosis associated with tumor necrosis factor-alpha inhibitor treatment. JAAD Case Rep. 2015 Nov; 1(6):418-20. PMID: 27051797.
      View in: PubMed
    3. Comfere NI, Ikediobi ON, Peters MS, el-Azhary RA, Gibson LE. Pharmacogenetics in dermatology: a patient-centered update. Int J Dermatol. 2013 Aug; 52(8):1005-12. PMID: 23786543.
      View in: PubMed
    4. Coetzee B, Kagee A, Tomlinson M, Warnich L, Ikediobi O. Reactions, beliefs and concerns associated with providing hair specimens for medical research among a South African sample: a qualitative approach. Future Virol. 2012 Nov 01; 7(11):1135-1142. PMID: 23646064.
      View in: PubMed
    5. Walko CM, Ikediobi O. Pharmacogenomic applications in oncology. J Pharm Pract. 2012 Aug; 25(4):439-46. PMID: 22907843.
      View in: PubMed
    6. Odierna DH, Afable-Munsuz A, Ikediobi O, Beattie M, Knight S, Ko M, Wilson A, Ponce NA. Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes? Per Med. 2011 Nov; 8(6):669-679. PMID: 22190978.
      View in: PubMed
    7. Ikediobi O, Aouizerat B, Xiao Y, Gandhi M, Gebhardt S, Warnich L. Analysis of pharmacogenetic traits in two distinct South African populations. Hum Genomics. 2011 May; 5(4):265-82. PMID: 21712189.
      View in: PubMed
    8. Marques SC, Ikediobi ON. The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions. Hum Genomics. 2010 Apr; 4(4):238-49. PMID: 20511137.
      View in: PubMed
    9. Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O, Pommier YG, Weinstein JN. Multifactorial regulation of E-cadherin expression: an integrative study. Mol Cancer Ther. 2010 Jan; 9(1):1-16. PMID: 20053763.
      View in: PubMed
    10. Ikediobi ON, Shin J, Nussbaum RL, Phillips KA, Walsh JM, Ladabaum U, Marshall D. Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther. 2009 Jul; 86(1):28-31. PMID: 19536122.
      View in: PubMed
    11. Ikediobi ON. Personalized medicine: are we there yet? Pharmacogenomics J. 2009 Apr; 9(2):85. PMID: 18794909.
      View in: PubMed
    12. Ikediobi ON. Somatic pharmacogenomics in cancer. Pharmacogenomics J. 2008 Oct; 8(5):305-14. PMID: 18679398.
      View in: PubMed
    13. Ikediobi ON, Reimers M, Durinck S, Blower PE, Futreal AP, Stratton MR, Weinstein JN. In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation. Mol Cancer Ther. 2008 Jun; 7(6):1337-46. PMID: 18524847.
      View in: PubMed
    14. Ikediobi ON, Davies H, Bignell G, Edkins S, Stevens C, O'Meara S, Santarius T, Avis T, Barthorpe S, Brackenbury L, Buck G, Butler A, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Hunter C, Jenkinson A, Jones D, Kosmidou V, Lugg R, Menzies A, Mironenko T, Parker A, Perry J, Raine K, Richardson D, Shepherd R, Small A, Smith R, Solomon H, Stephens P, Teague J, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Reinhold W, Weinstein JN, Stratton MR, Futreal PA, Wooster R. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther. 2006 Nov; 5(11):2606-12. PMID: 17088437.
      View in: PubMed
    15. Shaik MS, Haynes A, McSween J, Ikediobi O, Kanikkannan N, Singh M. Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug. J Aerosol Med. 2002; 15(3):261-70. PMID: 12396414.
      View in: PubMed
    16. Shaik MS, Ikediobi O, Turnage VD, McSween J, Kanikkannan N, Singh M. Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs. J Pharm Pharmacol. 2001 May; 53(5):617-27. PMID: 11370701.
      View in: PubMed